{"schema_version":"secwatch.filing_event.v1","accession":"0001739410-25-000041","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.676086+00:00","generated_at":"2026-05-24T21:27:21.436733+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Rallybio reduces ATM offering cap from $100M to $9.55M under Sales Agreement with TD Cowen","bullets":["Amendment reduces aggregate offering price from $100,000,000 to $9,550,000.","As of March 13, 2025, no shares have been sold under the Sales Agreement.","TD Cowen receives up to 3.0% commission on gross proceeds in at-the-market sales.","Sales limited by public float rule: cannot exceed one-third of non-affiliate market value if public float <$75M."],"urls":{"canonical":"https://secwatch.observer/filing/0001739410-25-000041","json":"https://secwatch.observer/filing/0001739410-25-000041.json","markdown":"https://secwatch.observer/filing/0001739410-25-000041.md","text":"https://secwatch.observer/filing/0001739410-25-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000173941025000041/0001739410-25-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000173941025000041/rlyb-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:27:21.436733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}